Compare Pinterest Inc (PINS) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pinterest Inc vs GeneDx Holdings Corp — how do they compare? Pinterest Inc trades at $21.4 (market cap $11.63B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Pinterest Inc is far larger — about 5.8× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is more actively traded (734,640 versus 12,792,940). Which is the better fit depends on your goals — on Pluang, investors hold Pinterest Inc for 85 Days and GeneDx Holdings Corp for 19 Days on average.
| PINS | WGS | |
|---|---|---|
Market Cap | $11.63B | $2.02B |
Volume | 12,792,940 | 734,640 |
Sector | Media | Health |
52-Week High | $35.24 | $167.51 |
52-Week Low | $15.42 | $34.51 |
Typical Hold Time | 85 Days | 19 Days |
Enterprise Value | $11.55B | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pinterest (PINS) trades at $20.525, up 1.06% today, with a bullish technical signal from moving averages but a bearish oscillator reading. The company reported strong revenue growth to $4.22 billion in 2025, with net income of $416.86 million, and has beaten EPS estimates in recent quarters. Analyst consensus is bullish with a $27.93 price target, though insider selling and negative net cash flow trends present cautionary notes.
The outlook for PINS is positive given its revenue growth trajectory and high gross margins, but valuation multiples like a P/E of 60.38 suggest premium pricing. Risks include reliance on advertising monetization and competitive pressures. Upside potential exists if international monetization accelerates and earnings continue to exceed expectations.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
